We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA is seeking stakeholder feedback on a proposed initiative that would encourage drugmakers to use an updated drug labeling format even if they are not legally required to do so.